Trial intelligence / Profile preview

Vitamin D Supplementation in Ulcerative Colitis

NCT04309058Phase 1Unknown

Sponsor
The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
Start
Mar 2020
Primary completion
Mar 2021
Countries
1
01

Overview

Phase 1, open-label trial (2 arms), sponsored by The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University. Primary endpoints: Genotype frequency of vitamin D receptor single nucleotide polymorphisms at 1 year and Serum 25 (OH) D level at 12 months. Status: unknown.

Beyond the preview

Go deeper on NCT04309058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04309058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call